Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Possible osteosarcopenia linked to lower intrinsic capacity and early cognitive deficits in Singapore older adults

In a Singapore household survey of 2,291 older adults, possible osteosarcopenia was common and was associated with lower intrinsic capacity at baseline and poorer cognition at 6 months. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Possible osteosarcopenia, defined as concurrent possible osteoporosis and possible sarcopenia, was observed among 50.3% of the cohort. [1]

  2. Possible osteosarcopenia was associated with lower intrinsic capacity at baseline, including cognition capacity. [1]

  3. Baseline possible osteosarcopenia was associated with poor cognitive function at 6 months after baseline, particularly among those with loss in cognitive capacity at baseline. [1]

The source at a glance

Study type / format
Longitudinal observational study (abstract).
Population / context
2,291 older adults recruited through a national household survey in Singapore.
Summary based on
Study abstract
Original publication
October 1, 2026

Singapore survey of 2,291 older adults

Participants were recruited through a national household survey of older adults in Singapore. Questionnaires and physical assessments at baseline collected socio-demographic, health and psychosocial variables. Possible osteosarcopenia was defined as the concurrent presence of possible osteoporosis and possible sarcopenia. The study reports that this possible osteosarcopenia was observed among 50.3% of the cohort.

Supporting source [1]

Lower intrinsic capacity at baseline, poorer cognition at 6 months

Using multilevel mixed-effects regression models, the authors examined associations of possible osteosarcopenia with intrinsic capacity at baseline and with cognitive function at 6 months after baseline. Possible osteosarcopenia was associated with lower intrinsic capacity at baseline, including cognition capacity. Baseline possible osteosarcopenia was also associated with poor cognitive function at 6 months, particularly among those with loss in cognitive capacity at baseline. This was driven by impaired delayed recall and poor orientation abilities.

Supporting source [1]

Education, social networks and resilience linked to better capacity

The authors also report that higher education, social networks, resilience and quality of life were associated with better intrinsic capacity at baseline and better cognition at baseline and at 6 months after baseline. These are associations, not evidence that any factor causes better capacity or cognition. The abstract does not report effect sizes, confidence intervals or adjustment details, and the full text was not reviewed.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. The abstract reports associations, not causes, and gives no effect sizes, confidence intervals or adjustment details.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Possible osteosarcopenia is associated with loss in intrinsic capacity and early cognitive deficits: a longitudinal study of older adults in Singapore.

Koh VJW, Khong TMT, Troeung L, Malhotra R, Jha D, Praveen AD, Liu YX, Helgason B, Singh NB, Chan AWM. · europepmc.org · October 1, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    observed among 50.3% of the cohort
  2. Finding 2 ↑

    associated with lower IC at baseline
  3. Finding 3 ↑

    poor cognitive function at 6 months post-baseline

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…